SCHEMBL351911

SCHEMBL351911

[NH]C(=O)Nc1cc(Cl)cc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
MAPT P10636 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
RAB9A P51151 2/20 0.53
POLB P06746 2/20 0.50
P2RY1 P47900 1/20 0.50
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
XBP1 P17861 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ACP1 P24666 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
P2RX1 P51575 1/20 0.47
P2RX4 Q99571 1/20 0.47
P2RX7 Q99572 1/20 0.47
TMPRSS4 Q9NRS4 1/20 0.47
FABP4 P15090 1/20 0.47
IDO1 P14902 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15786287 0.80 MEN1 (0.76) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL1465075 0.79 MEN1 (0.71) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL9835677 0.78 MEN1 (0.55) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL2090730 0.78 MEN1 (0.55) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL711831 0.78 MEN1 (0.61) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL3890955 0.76 MEN1 (0.53) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL2795008 0.76 NPC1 (0.61) MEN1KMT2AMAPTRAB9APOLB
SCHEMBL2728856 0.76 LMNA (0.58) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL2891974 0.76 NPC1 (0.61) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL15708598 0.74 EGFR (0.66) MEN1KMT2AMAPTNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 MEN1 186/4885KMT2A 1523/4885MAPT 2648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.